US 8993266
Proproteins activatable interferon alpha
granted A61KA61K38/00A61K47/64
Quick answer
US patent 8993266 (Proproteins activatable interferon alpha) held by CytomX Therapeutics, Inc. expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00, A61K47/64, A61K47/65, A61P